Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. U.S.A., 100, 3983, 10.1073/pnas.0530291100 Bar, 2010, Hypoxia increases the expression of stem cell markers and promotes clonogenicity in glioblastoma neurospheres, Am. J. Pathol, 177, 491, 10.2353/ajpath.2010.091021 Bendinelli, 2013, Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer, Eur. J. Cancer, 49, 2608, 10.1016/j.ejca.2013.03.002 Bhola, 2013, TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer, J. Clin. Invest, 123, 1348, 10.1172/JCI65416 Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med, 3, 730, 10.1038/nm0797-730 Bos, 2001, Levels of hypoxia-inducible factor-1α during breast carcinogenesis, J. Natl Cancer Inst, 93, 309, 10.1093/jnci/93.4.309 Boyer, 2005, Core transcriptional regulatory circuitry in human embryonic stem cells, Cell, 122, 947, 10.1016/j.cell.2005.08.020 Cancer Genome Atlas Network, 2012, Comprehensive molecular portraits of human breast tumors, Nature, 490, 61, 10.1038/nature11412 Cao, 2013, Tumor cells upregulate normoxic HIF-1α in response to doxorubicin, Cancer Res, 73, 6230, 10.1158/0008-5472.CAN-12-1345 Collins, 2005, Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res, 65, 10946, 10.1158/0008-5472.CAN-05-2018 Comerford, 2002, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene, Cancer Res, 62, 3387 Conley, 2012, Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia, Proc. Natl. Acad. Sci. U.S.A., 109, 2784, 10.1073/pnas.1018866109 Conley, 2015, CRLX101, an investigational camptothecin-containing nanoparticle- drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer, Breast Cancer Res. Treat, 150, 559, 10.1007/s10549-015-3349-8 Creighton, 2009, Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features, Proc. Natl. Acad. Sci. U.S.A., 106, 13820, 10.1073/pnas.0905718106 Danet, 2003, Expansion of human SCID-repopulating cells under hypoxic conditions, J. Clin. Invest, 112, 126, 10.1172/JCI17669 Dean, 2005, Tumor stem cells and drug resistance, Nat. Rev. Cancer, 5, 275, 10.1038/nrc1590 Dent, 2007, Triple-negative breast cancer: clinical features and patterns of recurrence, Clin. Cancer Res, 13, 4429, 10.1158/1078-0432.CCR-06-3045 Eliasson, 2010, The hematopoietic stem cell niche: low in oxygen but a nice place to be, J. Cell. Physiol, 222, 17, 10.1002/jcp.21908 Ezashi, 2005, Low O2 tensions and the prevention of differentiation of hES cells, Proc. Natl. Acad. Sci. U.S.A., 102, 4783, 10.1073/pnas.0501283102 Fang, 2005, A tumorigenic subpopulation with stem cell properties in melanomas, Cancer Res, 65, 9328, 10.1158/0008-5472.CAN-05-1343 Fehrer, 2007, Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan, Aging Cell, 6, 745, 10.1111/j.1474-9726.2007.00336.x Folmes, 2011, Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming, Cell Metab, 14, 264, 10.1016/j.cmet.2011.06.011 Forristal, 2010, Hypoxia- inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions, Reproduction, 139, 85, 10.1530/REP-09-0300 Foulkes, 2010, Triple-negative breast cancer, N. Engl. J. Med, 363, 1938, 10.1056/NEJMra1001389 Ghosh, 2009, Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells, Blood, 113, 5568, 10.1182/blood-2008-10-185686 Ginestier, 2010, CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts, J. Clin. Invest, 120, 485, 10.1172/JCI39397 Guitart, 2013, HIF-2α is not essential for cell-autonomous hematopoietic stem cell maintenance, Blood, 122, 1741, 10.1182/blood-2013-02-484923 Gustafsson, 2005, Hypoxia requires notch signaling to maintain the undifferentiated state, Dev. Cell, 9, 617, 10.1016/j.devcel.2005.09.010 Heddleston, 2009, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, 8, 3274, 10.4161/cc.8.20.9701 Helczynska, 2003, Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ, Cancer Res, 63, 1441 Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1, 313, 10.1016/j.stem.2007.06.002 Hope, 2004, Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity, Nat. Immunol, 5, 738, 10.1038/ni1080 Hu, 2006, Differential regulation of the transcriptional activities of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in stem cells, Mol. Cell. Biol, 26, 3514, 10.1128/MCB.26.9.3514-3526.2006 Hubbi, 2013, A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication, Sci. Signal, 6, 10.1126/scisignal.2003417 Hubbi, 2014, Cyclin- dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression, Proc. Natl. Acad. Sci. U.S.A., 111, E3325, 10.1073/pnas.1412840111 Iida, 2012, Hypoxia induces CD133 expression in human lung cancer cells by upregulation of OCT3/4 and SOX2, Int. J. Oncol, 40, 71 Imanirad, 2014, HIF-1α is a regulator of hematopoietic progenitor and stem cell development in hypoxic sites of the mouse embryo, Stem Cell Res, 12, 24, 10.1016/j.scr.2013.09.006 Jang, 2007, A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche, Blood, 110, 3056, 10.1182/blood-2007-05-087759 Kiel, 2008, Uncertainty in the niches that maintain hematopoietic stem cells, Nat. Rev. Immunol, 8, 290, 10.1038/nri2279 Kim, 2006, HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia, Cell Metab, 3, 177, 10.1016/j.cmet.2006.02.002 Kong, 2005, Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor 1 DNA- binding activity, Cancer Res, 65, 9047, 10.1158/0008-5472.CAN-05-1235 Koshiji, 2004, HIF- 1α induces cell cycle arrest by functionally counteracting Myc, EMBO J., 23, 1949, 10.1038/sj.emboj.7600196 Lapidot, 1994, A cell initiating human acute myeloid leukemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Li, 2008, Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy, J. Natl Cancer Inst, 100, 672, 10.1093/jnci/djn123 Li, 2009, Hypoxia- inducible factors regulate tumorigenic capacity of glioma stem cells, Cancer Cell, 15, 501, 10.1016/j.ccr.2009.03.018 Lim, 2014, Inhibition of monocarboxylate transporter 4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner, Oncogene, 33, 4433, 10.1038/onc.2013.390 Loenarz, 2011, The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adherens, EMBO Rep, 12, 63, 10.1038/embor.2010.170 Loh, 2006, The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells, Nat. Genet, 38, 431, 10.1038/ng1760 Lu, 2015, Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype, Proc. Natl. Acad. Sci. U.S.A., 112, E4600, 10.1073/pnas.1513433112 Ma, 2015, Hypoxia regulates Hippo signaling through the SIAH2 ubiquitin E3 ligase, Nat. Cell Biol, 17, 95, 10.1038/ncb3073 Makino, 2002, Inhibitory PAS domain protein (iPAS) is a hypoxia-inducible splicing variant of the hypoxia- inducible factor 3α locus, J. Biol. Chem, 282, 14073 Marotta, 2011, The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24− stem cell-like breast cancer cells in human tumors, J. Clin. Invest, 121, 2723, 10.1172/JCI44745 Mathieu, 2013, Hypoxia induces re-entry of committed cells into pluripotency, Stem Cells, 31, 1737, 10.1002/stem.1446 Mathieu, 2011, HIF induces human embryonic stem cell markers in cancer cells, Cancer Res, 71, 4640, 10.1158/0008-5472.CAN-10-3320 Mathieu, 2014, Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency, Cell Stem Cell, 14, 592, 10.1016/j.stem.2014.02.012 Mazumdar, 2010, O2 regulates stem cells through Wnt/β-catenin signaling, Nat. Cell Biol, 12, 1007, 10.1038/ncb2102 McCord, 2009, Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro, Mol. Cancer Res, 7, 489, 10.1158/1541-7786.MCR-08-0360 Mohyeldin, 2010, Oxygen in stem cell biology: a critical component of the stem cell niche, Cell Stem Cell, 7, 150, 10.1016/j.stem.2010.07.007 O'Brien, 2007, A human colon cancer cell capable of initiating tumor growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372 Ohnishi, 2013, Hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors, PLoS ONE, 8, e66255, 10.1371/journal.pone.0066255 Oliveira-Costa, 2011, Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas, Diagn. Pathol, 6, 73, 10.1186/1746-1596-6-73 Oliver, 2004, The renal papilla is a niche for adult kidney stem cells, J. Clin. Invest, 114, 795, 10.1172/JCI20921 Orkin, 2008, Hematopoiesis: an evolving paradigm for stem cell biology, Cell, 132, 631, 10.1016/j.cell.2008.01.025 Papandreou, 2006, HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption, Cell Metab, 3, 187, 10.1016/j.cmet.2006.01.012 Parmar, 2007, Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia, Proc. Natl. Acad. Sci. U.S.A., 104, 5431, 10.1073/pnas.0701152104 Pastan, 1991, Multidrug resistance, Annu. Rev. Med, 42, 277, 10.1146/annurev.me.42.020191.001425 Perry, 2007, Disrupting the stem cell niche: good seeds in bad soil, Cell, 129, 1045, 10.1016/j.cell.2007.05.053 Petruzzelli, 2014, HIF-2α regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox cis regulatory element, PLoS ONE, 9, e108309, 10.1371/journal.pone.0108309 Ponti, 2005, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Cancer Res, 65, 5506, 10.1158/0008-5472.CAN-05-0626 Prabhakar, 2012, Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2, Physiol. Rev, 92, 967, 10.1152/physrev.00030.2011 Prince, 2007, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proc. Natl. Acad. Sci. U.S.A., 104, 973, 10.1073/pnas.0610117104 Qiang, 2012, HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway, Cell Death Differ, 19, 284, 10.1038/cdd.2011.95 Rohwer, 2011, Hypoxia-mediated drug resistance: novel insights into the functional interaction of HIFs and cell death pathways, Drug Resist. Updat, 14, 191, 10.1016/j.drup.2011.03.001 Ross, 2007, Human neuroblastoma stem cells, Semin. Cancer Biol, 17, 241, 10.1016/j.semcancer.2006.04.006 Samanta, 2014, Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells, Proc. Natl. Acad. Sci. U.S.A., 111, E5429, 10.1073/pnas.1421438111 Sansone, 2007, IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland, J. Clin. Invest, 117, 3988, 10.1172/JCI32533 Schwab, 2012, Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer, Breast Cancer Res, 14, R6, 10.1186/bcr3087 Semenza, 2013, HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations, J. Clin. Invest, 123, 3664, 10.1172/JCI67230 Semenza, 2015, The hypoxic tumor microenvironment: a driving force for breast cancer progression, Biochim. Biophys. Acta Singh, 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res, 63, 5821 Soeda, 2009, Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α, Oncogene, 28, 3949, 10.1038/onc.2009.252 Suda, 2011, Metabolic regulation of hematopoietic stem cells in the hypoxic niche, Cell Stem Cell, 9, 298, 10.1016/j.stem.2011.09.010 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Takubo, 2010, Regulation of the HIF-1α level is essential for hematopoietic stem cells, Cell Stem Cell, 7, 391, 10.1016/j.stem.2010.06.020 Takubo, 2013, Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells, Cell Stem Cell, 12, 49, 10.1016/j.stem.2012.10.011 Tian, 1997, Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells, Genes Dev, 11, 72, 10.1101/gad.11.1.72 Unruh, 2003, The hypoxia-inducible factor 1α is a negative factor for tumor therapy, Oncogene, 22, 3213, 10.1038/sj.onc.1206385 Vaupel, 2007, Detection and characterization of tumor hypoxia using pO2 histography, Antioxid. Redox Signal, 9, 1221, 10.1089/ars.2007.1628 Wang, 1995, Purification and characterization of hypoxia-inducible factor 1, J. Biol. Chem, 270, 1230, 10.1074/jbc.270.3.1230 Wang, 1995, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc. Natl. Acad. Sci. U.S.A., 92, 5510, 10.1073/pnas.92.12.5510 Wang, 2011, Targeting HIF-1α eliminates cancer stem cells in hematological malignancies, Cell Stem Cell, 8, 399, 10.1016/j.stem.2011.02.006 Wang, 2014, Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells, Blood, 124, 1127, 10.1182/blood-2013-12-544221 Weigelt, 2009, Histological and molecular types of breast cancer, Nat. Rev. Clin. Oncol, 6, 718, 10.1038/nrclinonc.2009.166 Xiang, 2014, Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer, J. Mol. Med, 92, 151, 10.1007/s00109-013-1102-5 Xiang, 2014, Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype, Oncotarget, 5, 12509, 10.18632/oncotarget.2997 Xiang, 2015, HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells, Oncotarget, 6, 11768, 10.18632/oncotarget.4190 Yoshida, 2009, Hypoxia enhances the generation of induced pluripotent stem cells, Cell Stem Cell, 5, 237, 10.1016/j.stem.2009.08.001 Zagzag, 2000, Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression, Cancer, 88, 2606, 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W Zhang, 2012, HIF-1α is required for survival maintenance of chronic myeloid leukemia stem cells, Blood, 119, 2595, 10.1182/blood-2011-10-387381 Zhang, 2014, Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia, Cell Rep, 6, 1110, 10.1016/j.celrep.2014.02.011 Zhong, 1999, Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases, Cancer Res, 59, 5830 Zhou, 2012, HIF-1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition, EMBO J., 31, 2103, 10.1038/emboj.2012.71